Ahmed Hamed Salem, PhD, FCP¹, Mohamed A Badawi, PhD^1*, Andrew E. Place, MD, PhD², Tammy L. Palenski, PhD¹, Richard Arrendale, PhD^1*, Su Young Kim^1*, Sara Federico, MD^3*, Todd M. Cooper, DO⁴ and Rajeev Menon, PhD^1*

¹AbbVie Inc., North Chicago, IL
²Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
³St. Jude Children's Research Hospital, Memphis, TN
⁴Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA

Alex Bataller, MD^1*, Ana Garrido, MD^2*, Francesca Guijarro, MD^1*, Marina Diaz-Beyá, MD^1*, Guadalupe Oñate, MD^2*, Montserrat Hoyos^2*, Montserrat Arnan, MD^3*, Mar Tormo, MD⁴, Susana Vives, MD^5*, Maria Paz Queipo De Llano, MD^6*, Olga Salamero, MD^7*, Rosa Coll, MD^8*, David Gallardo, MD^8*, Ferran Vall-Llovera, MD^9*, Lourdes Escoda, MD^10*, Antonia Sampol, MD¹¹, Antonio Garcia-Guiñon, MD^12*, Brayan Merchan, MD^13*, Joan Bargay, MD^14*, Monica Lopez-Guerra, PhD^15*, Marta Pratcorona, MD^2*, Lurdes Zamora, PhD^5*, Salut Brunet, MD^2*, Josep F Nomdedeu, MD^2*, Jorge Sierra, MD² and Jordi Esteve, MD, PhD¹

¹Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
²Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
³Hematology Department, ICO - Hospital Duran i Reynals, Hospitalet del Llobregat, Spain
⁴Hospital Clínico Universitario de Valencia, Valencia, Spain
⁵Hematology Department, ICO - Hospital Germans Trias i Pujol, Badalona, Spain
⁶Hospital Universitario Virgen de la Victoria, Málaga, Spain
⁷Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
⁸Hematology Department, ICO - Hospital Doctor Josep Trueta, Girona, Spain
⁹Hematology Department, Hospital Mutua de Terrassa, Terrassa, Spain
¹⁰Hematology Department, ICO - Hospital Joan XXIII, Tarragona, Spain
¹¹Department of Hematology, Hospital Universitari Son Espases, IdISBa, Palma de Mallorca, Spain
¹²Hematology Department, Hospital Arnau de Vilanova, Lleida, Spain
¹³Hematology Department, Hospital del Mar, Barcelona, Catalonia, Spain
¹⁴Department of Hematology, Son Llatzer University Hospital/ IdISBa, Palma de Mallorca, Spain
¹⁵Hematopathology Section, Hospital Clínic de Barcelona, Barcelona, Spain

Jorge M. Ramos Perez^1*, Tapan M. Kadia, MD¹, Guillermo Montalban-Bravo, MD^1*, Stefan Faderl, MD^2*, Koji Sasaki, MD³, Naval Daver, MD⁴, Courtney D. DiNardo, MD, MSc⁵, Lucia Masarova, MD^1*, Alessandra Ferrajoli, MD⁶, Elias Jabbour, MD¹, Gautham Borthakur^1*, Hind Al Azzawi^1*, Naveen Pemmaraju, MD¹, Marina Konopleva, MD, PhD⁷, Sherry A. Pierce, BSN, BA^1*, Guillermo Garcia-Manero, MD¹, Michael Andreeff, MD, PhD⁸, Hagop M. Kantarjian, MD⁹, Farhad Ravandi, MBBS¹⁰ and Yesid Alvarado, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Jazz Pharmaceuticals, Palo Alto, CA
³Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX
⁸Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Leukemia, Professor and Chairman, Department of Leukemia, Samsung Distinguished University Chair in Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

Nicholas J. Short, MD¹, Farhad Sedarati^2*, Dan Zhao^2*, Olga Tsukurov^2*, Sharon Friedlander^3* and Douglas V. Faller^2*

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA
³Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA

Guido Marcucci, MD¹, Drew Watson, Ph.D.^2*, Prashant Ramachandran Nair, B.Tech.^3*, Kabya Basu, M.Sc.^3*, Yashaswini S Ullal, M.Tech.^3*, Adity Ghosh, M.Sc.^3*, Yugandhara Narvekar, M.Sc.^3*, Himanshu Grover, M.S.^3*, Diwyanshu Sahu, M.Sc.^3*, Anish Raju R Amara, B.E.^3*, Anusha Pampana, M.Sc.^3*, Kunal Ghosh Roy, M.Sc.^3*, Swaminathan Rajagopalan, M.Tech.^3*, Aftab Alam, M.Sc.^3*, Rajan Parashar, B.Tech.^3*, Nirjhar Mundkur^2*, James Christie, B.S.^2*, Michele Dundas Macpherson, B.A.Sc.^2*, Shweta Kapoor, M.Sc.^3* and Anthony S. Stein, MD¹

¹Gehr Family Center for Leukemia Research, Department of Hematologic Malignancies Translational Science, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA
²Cellworks Group Inc., South San Francisco, CA
³Cellworks Research India Private Limited, Bangalore, India

Dries Deeren, MD, PhD¹, Johan A. Maertens, MD, PhD^2*, Tara Lin, MD³, Yves Beguin, MD, PhD⁴, Benjamin Demoulin, PhD^5*, Martina Fontaine, PhD^5*, Panagiota A. Sotiropoulou, PhD^5*, Erik Alcantar-Orozco, MD^5*, Eytan Breman^5*, Marie-Sophie Dheur, PhD, PharmD^5*, Nathalie Braun^5*, Caroline Lonez, PhD^6*, David E Gilham, PhD^5*, Anne Flament, MD^5* and Frédéric F. Lehmann, MD^5*

¹Algemeen Ziekenhuis (AZ) Delta, Roeselare, Belgium
²University Hospital Leuven, Leuven, Belgium
³University of Kansas Medical Center, Kansas City, KS
⁴Centre Hospitalier Universitaire de Liège, Liege, Belgium
⁵Celyad Oncology, Mont-Saint-Guibert, Belgium
⁶Celyad Oncology, Mont-saint-Guibert, Belgium

Amandeep Salhotra, MD¹, Dat Ngo, PharmD^2*, Jianying Zhang^3*, Karamjeet S. Sandhu, MD⁴, Monzr M. Al Malki, MD⁴, Ahmed Aribi, MD^5*, Haris Ali, MD⁶, Pkoller Koller, MD⁷, Shukaib Arslan, MD⁴, Andrew S. Artz, MD, MS⁸, Lihua E Budde, MD, PhD⁹, Samer Khaled, MD¹⁰, Sanjeet S Dadwal, MD¹¹, David S Snyder, MD⁴, Stephen J. Forman, MD¹⁰, Ryotaro Nakamura, M.D.¹⁰, Anthony S. Stein, MD⁵, Guido Marcucci, MD¹², Ibrahim Aldoss, M.D.⁴ and Vinod A. Pullarkat, MD¹⁰

¹Department of Hematology/HCT, City of Hope, Pasadena, CA
²Pharmacy, City of Hope National Medical Center, Duarte, CA
³Division of Biostastics, City of Hope National Medical Center, Duarte, CA
⁴Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
⁵City of Hope National Medical Center, Duarte, CA
⁶City of Hope Medical Center, Duarte, CA
⁷Department of Hematology/HCT, City of Hope, Duarte, CA
⁸City of Hope, Duarte, CA
⁹Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
¹⁰Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
¹¹Division of Infectious Disease, City of Hope National Medical Center, Duarte, CA
¹²Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope, Monrovia, CA

Shruti N. Shah, BS^1,2* and Gustavo A. Rivero, MD^3,4,5

¹Baylor College of Medicine, Houston, TX
²Wiess School of Natural Sciences, Rice University, Missouri City, TX
³Section of Hematology and Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX
⁴Michael E. DeBakey VA Medical Center, Houston, TX
⁵Dan L Duncan Comprehensive Cancer at Baylor St. Luke's Medical Center, Houston, TX

David A. Sallman, MD¹, A. Samer Al-Homsi, MD², Marco L. Davila, MD, PhD¹, Tessa Kerre, MD^3*, Ine Moors, MD^3*, Xavier Poire, MD^4*, Violaine Havelange, MD^4*, Philippe Lewalle, MD^5*, Daniel A. Pollyea, MD⁶, Eunice S. Wang, MD⁷, William Blum, MD⁸, Benjamin Demoulin, PhD^9*, Panagiota A. Sotiropoulou, PhD^9*, Erik Alcantar-Orozco, MD^9*, Eytan Breman^9*, Marie-Sophie Dheur, PhD, PharmD^9*, Nathalie Braun^9*, Caroline Lonez, PhD^10*, David E Gilham, PhD^9*, Anne Flament, MD^9* and Frédéric F. Lehmann, MD^9*

¹H. Lee Moffitt Cancer Center, Tampa, FL
²NYU Langone Health, New York University School of Medicine, New York, NY
³Ghent University Hospital, Gent, Belgium
⁴Cliniques Universitaires Saint-Luc, Brussels, Belgium
⁵Institut Jules Bordet (ULB), Brussels, Belgium
⁶UCHealth University of Colorado Hospital, Denver, CO
⁷Roswell Park Comprehensive Cancer Center, BUFFALO, NY
⁸Emory University Hospital, Atlanta, GA
⁹Celyad Oncology, Mont-Saint-Guibert, Belgium
¹⁰Celyad Oncology, Mont-saint-Guibert, Belgium

Shukaib Arslan, MD¹, Jianying Zhang^2*, Prajwal Dhakal, MBBS³, Jenna A. Moran, NP^4*, Nuthana Naidoo^5*, Jennifer Lombardi Story^6*, Vinod A. Pullarkat, MD⁷, Anthony S. Stein, MD⁸, Guido Marcucci, MD⁹, George Yaghmour, MD⁵, Vijaya R. Bhatt, MD³, Amir T. Fathi¹⁰ and Ibrahim Aldoss, M.D.¹¹

¹Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
²Division of Biostastics, City of Hope National Medical Center, Duarte, CA
³Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE
⁴Leukemia Center, Massachusetts General Hospital, Boston, MA
⁵USC Norris Cancer Hospital, Los Angeles, CA
⁶Leukemia Program, Massachusetts General Hospital, Boston, MA
⁷City of Hope Comprehensive Cancer Center, Duarte, CA
⁸City of Hope National Medical Center, Duarte, CA
⁹Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematologic Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope, Monrovia, CA
¹⁰Leukemia Center, Massachusetts General Hospital, Center for Leukemia, Cambridge, MA
¹¹Hemtology/HCT, City of Hope National Medical Center, Duarte, CA

Alexander E. Perl, MD¹, Qiaoyang Lu, MS^2*, Alan Fan, MS Pharm^2*, Nahla Hasabou, MD^2*, Erhan Berrak, MD^2* and Ramon V. Tiu, MD^2*

¹Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²Astellas Pharma, Inc., Northbrook, IL

Yazan F. Madanat, MD¹, Hetalkumari Patel, PharmD, BCOP^2*, Omik Patel, PharmD, BCOP^2*, Jingsheng Yan, PhD^3*, Jude Khatib, MD^1*, Madhuri Vusirkala, MD^1*, Suleyman Y Goksu, MD^1*, Chul Ahn, PhD^4*, Prapti Patel, MD⁵, Robert H. Collins, MD¹ and Stephen Chung, MD¹

¹Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
²Department of Pharmacy, UT Southwestern Medical Center, Dallas, TX
³Biostatistics Shared Resources, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁴Biostatistics shared resources, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁵Simmons Comprehensive Cancer Center, Harold C Simmons Comprehensive Cancer Center, Dallas, TX

Patrick K Reville, MD¹, Graciela M. Nogueras González, MPH^2*, Farhad Ravandi, MBBS³, Koji Sasaki, MD³, Gautam Borthakur, MD³, Guillermo Garcia-Manero, MD³, Naval Daver, MD³, Courtney D. DiNardo, MD, MSc³, Elias Jabbour, MD³, Naveen Pemmaraju, MD³, Michael Andreeff, MD, PhD⁴, Srdan Verstovsek, MD, PhD³, Alessandra Ferrajoli, MD³, Nitin Jain, MD³, Maro Ohanian, DO^3*, Sherry A. Pierce, BSN, BA^3*, Zeev E. Estrov, MD³, Marina Konopleva, MD, PhD⁵, Hagop M. Kantarjian, MD³ and Tapan M. Kadia, MD³

¹Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX

Naval Daver, MD¹, Kyoo Hyung Lee, MD, PhD^2*, Chul Won Jung, MD, PhD^3*, Yoon Sung Soo, MD, PhD^4*, Martha L. Arellano, MD⁵, Brian A Jonas, MD, PhD, FACP⁶, Jiyeon Yoon, PhD^7*, Sooa Jung, PhD^8*, Young Su Noh, PhD^7*, Inhwan Bae, PhD^7* and Song Kim, MD^7*

¹Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
²Department of Internal Medicine, University of Ulsan, College of Medicine and Asan Medical Center, Seoul, Korea, Republic of (South)
³Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
⁴Department of Internal Medicine, Seoul National University, College of Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁵Winship Cancer Institute of Emory University, Atlanta, GA
⁶Department of Internal Medicine, Division of Hematology and Oncology, University of California, Davis, Sacramento, CA
⁷Hanmi Pharmaceutical Co., Ltd., Seoul, Korea, Republic of (South)
⁸Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea

Shannon Murphy, MD, MBA¹, Brian Harnett, MD^2*, Kara Matheson^3*, David M. Jones, MD^4*, Abdulrahim Basendwah, MD⁵, Sudeep P Shivakumar, MD, BSc^6* and Mahmoud Elsawy, MB^6*

¹Dalhousie University, Halifax, NS, Canada
²Memorial University of Newfoundland, St. John's, Canada
³Research Methods Unit, Nova Scotia Health Authority, Centre for Clinical Research, NS health, halifax, Canada
⁴Memorial University, St John's, NL, CAN
⁵King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia
⁶Division of Hematology, Dalhousie University, Halifax, NS, Canada

Kunhwa Kim, MD MPH^1*, Marina Konopleva, MD, PhD¹, Courtney D. DiNardo, MD, MSc², Gautam Borthakur, MD¹, Guillermo Garcia-Manero, MD¹, Naveen Pemmaraju, MD¹, Naval Daver, MD¹, Elias Jabbour, MD¹, Steven M. Kornblau, MD¹, Musa Yilmaz, MD¹, Maro Ohanian, DO^1*, Alessandra Ferrajoli, MD¹, Nitin Jain, MD³, Nicholas J. Short, MD¹, Caitlin R. Rausch, PharmD^4*, Mark Brandt, BS^1*, Sherry A. Pierce, BSN, BA^1*, Zeev E. Estrov, MD¹, Farhad Ravandi, MBBS¹, Hagop M. Kantarjian, MD¹ and Tapan M. Kadia, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
³The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX

Susanne Ghandili^1*, Susanne Pfefferle^2*, Kevin Roedl^3*, Piet Sonnemann^1*, Panagiotis Karagiannis^1*, Olaf Boenisch^3*, Stefan Kluge^3*, Stefan Schmiedel^4*, Harald Ittrich^5*, Holger Rohde^2*, Marc Lütgehetmann^2*, Katja Weisel, MD^6*, Carsten Bokemeyer, MD^7*, Dominic Wichmann^3*, Walter Fiedler, MD⁸, Dominik Jarczak^3* and Franziska Modemann^1*

¹Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg Eppendorf, Hamburg, Germany
²Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg Eppendorf, Hamburg, Germany
³Department of Intensive Care Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
⁴I. Department of Internal Medicine, Division of Infectious Diseases, University Medical Center Hamburg Eppendorf, Hamburg, Germany
⁵Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany
⁶Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁷Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁸Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Hospital Eppendorf, Hamburg, Germany

Wenbing Duan^*, Xiaohong Liu^*, Jinsong JIA, MD, PhD^*, Jing Wang, MD^*, Lizhong Gong^*, Qian Jiang, MD, Ting Zhao^*, Yu Wang^*, Xiaohui Zhang^*, Lanping Xu^*, Xiaosu Zhao, PhD^*, Yazhen Qin^*, Hongxia Shi^*, Yingjun Chang, Xiaojun Huang^* and Hao Jiang, MD^*

Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

Qaiser Bashir, MD¹, Katayoun Rezvani¹, Neeraj Saini, MD¹, Elizabeth J. Shpall, MD¹, Samer A. Srour, MD, MS¹, Uday R. Popat, MD¹, Denái R. Milton, MS^2*, Naveen Pemmaraju, MD³, Richard E. Champlin, MD⁴ and Muzaffar H. Qazilbash, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

Fernanda Rodrigues Mendes^1,2*, Wellington F Silva, MD^2,3*, Raphael Bandeira Melo, MD^1,4*, Douglas R. A. Silveira^5*, Elvira Velloso, MD, PhD^6,7, Vanderson Rocha, MD, PhD^6,8,9* and Eduardo M Rego, MD, PhD^2,10,11

¹Division of Hematology, Instituto do Cancer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil, São Paulo, Brazil
²Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil, São Paulo, Brazil
³Instituto do Cancer do Estado de Sao Paulo da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil
⁴Division of Hematology, Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, Sao Paulo, Brazil, São Paulo, Brazil
⁵Division of Hematology, Hospital das Clínicas da Faculdade de Medicina (HCFMUSP), University of São Paulo Medical School, University of São Paulo, São Paulo, Brazil
⁶Instituto do Cancer de São Paulo (ICESP), University of São Paulo Medical School, University of São Paulo, São Paulo, Brazil
⁷Division of Hematology, Hospital das Clínicas , São Paulo Medical School, University of São Paulo, São Paulo, Brazil
⁸Division of Hematology, Transfusion Medicine and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
⁹Medical Research Laboratory on Molecular Hematology (LIM-31), Universidade de São Paulo, São Paulo, Brazil
¹⁰Medical Research Laboratory on Molecular Hematology (LIM-31), University of São Paulo, Sao Paulo, Sp, Brazil
¹¹Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

Candice Jamois, PharmD^1*, Doreen Anders^1*, Benjamin M. Beckermann, PhD¹, Magali Genevray, MD^1*, Kirsten Mundt, PhD^1*, Claire Petry^1*, Joy Yang^2*, Nastya Kassir^2* and Christophe Schmitt^1*

¹F. Hoffmann-La Roche, Ltd., Basel, Switzerland
²Certara, Montreal, Canada

Joana Brioso Infante, MD, MSc^1,2*, Graca Esteves, MD^2*, Helena Martins, MD^2*, Julia Medeiros, MD^2*, Daniela Alves, MD^2*, Conceicao Lopes, MD^2*, Maria Joao Costa, MD^2*, Maria Blanca Guerrero, MD^2*, Raul Moreno, MD^2*, Fernanda Lourenço, MD^2*, Carlos Martins, MD^2*, Joao F Lacerda, MD, PhD^1,2 and João Raposo, MD^2*

¹Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal
²Department of Hematology and Marrow Transplantation, Hospital de Santa Maria - Centro Hospitalar Lisboa Norte, Lisbon, Portugal

Megan Othus, PhD¹, Guillermo Garcia-Manero, MD², Harry P. Erba, MD, PhD³ and Elihu H. Estey, MD⁴

¹Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Duke University Medical Center, Durham, NC
⁴Department of Medicine, University of Washington, Seattle, WA

Dirk Reinhardt, MD¹, Henrik Hasle, MD², Karsten Nysom^3*, André Baruchel⁴, Franco Locatelli, MD, PhD⁵, Bouchra Benettaib^6*, Noha Biserna^6*, Meera Patturajan⁶, Mathew Simcock^7*, Allison Gaudy^6* and C. Michel Zwaan^8,9*

¹Department of Pediatric Hematology and Oncology, Essen University Hospital, Essen, Germany
²Pediatrics, Aarhus University Hospital, Aarhus, Denmark
³Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark
⁴Service d'Immuno-hématologie pédiatrique, Hôpital universitaire Robert-Debré AP-HP, Université de Paris, Paris, France
⁵Dipartimento di Ematologia ed Oncologia Pediatrica, IRCCS Ospedale Pediatrico Bambino Gesù, Sapienza, University of Rome, Rome, Italy
⁶Bristol Myers Squibb, Princeton, NJ
⁷Celgene Ltd., a Bristol-Myers Squibb Company, Uxbridge, United Kingdom
⁸Princess Máxima Centre for Pediatric Oncology, Utrecht, Netherlands
⁹Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands

Mohamed A Badawi, PhD^1*, Sathej Gopalakrishnan, PhD^1*, Benjamin Engelhardt, PhD^1*, Tammy L. Palenski, PhD¹, Su Young Kim^1*, Seth E. Karol, MD^2*, Jeffrey E. Rubnitz, MD³, Rajeev Menon, PhD^1* and Ahmed Hamed Salem, PhD, FCP¹

¹AbbVie Inc., North Chicago, IL
²St. Jude Children's Research Hospital, Memphis, TN
³Department of Oncology, St. Jude Children's Rsch. Hosp., Memphis, TN

Mallette M. Asmuth, MD¹, Anna B. Halpern, MD^2,3, Megan Othus, PhD^4*, Emily Huebner, MS^5*, Carole M. Shaw, BA^3*, Kelda Gardner, PA-C^2*, Elihu H. Estey, MD^2,3, Roland B. Walter, MD, PhD, MS^2,3,6,7 and Colin D. Godwin, MD, MPhil^2,3

¹Internal Medicine Residency Program, Department of Medicine, University of Washington, Seattle, WA
²Department of Medicine, University of Washington, Seattle, WA
³Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁴Public Health Science Division, Fred Hutchinson Cancer Research Center, Seattle
⁵University of Washington School of Medicine, Seattle, WA
⁶Department of Pathology and Laboratory Medicine, University of Washington, Seattle, WA
⁷Department of Epidemiology, University of Washington Medical Center, Seattle, WA

Prasanth Lingamaneni^1*, Vatsala Katiyar, MD², Krishna Moturi, MD^3*, Binav Baral, MD^1*, Ishaan Vohra, MD^4*, Trilok Shrivastava, MD^3* and Maryam Zia⁵

¹John H Stroger Hospital of Cook County, Chicago, IL
²Hematology/Oncology, University of Louisville, Louisville, KY
³John H. Stroger Hospital of Cook County, chicago, IL
⁴John H. Stroger Hospital of Cook County, Chicago, IL
⁵Division of Hematology/Oncology, John H Stroger Jr. Hospital of Cook County, Chicago, IL

Li Liu^1*, Xiaolei Pei^2*, Runzhi Ma^2*, Yi He^3*, Rongli Zhang, MD^3*, Jialin Wei^3*, Qiaoling Ma^3*, Weihua Zhai, MD^3*, Erlie Jiang^3*, Aiming Pang, MD, PhD^4*, Donglin Yang^3*, Sizhou Feng, MD, phD^5* and Ming-Zhe Han, MD³

¹Hematopoietic Stem Cell Transplantation Center, National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
³National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁴National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, Tianjin, China
⁵National Clinical Research Center for Blood Diseases,State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Uni, Tianjin, China

Seongseok Yun, MD, PhD¹, Onyee Chan, MD^1*, Daniel Kerr, MD PhD^2*, Nicole D. Vincelette, PhD^1,3, Afshan Idrees, MD, MPH^4*, Qianxing Mo, PhD^5*, Kendra Sweet, MD^6*, Jeffrey E. Lancet, MD⁶, Mohamed A kharfan-Dabaja, MD, MBA^7,8, Ling Zhang, MD^9* and Lubomir Sokol, MD, PhD^3,10

¹Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
³Moffitt Cancer Center, Tampa, FL
⁴Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁵Department of Biostatistics & Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁶Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁷Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
⁸Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
⁹Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹⁰H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL